What are the reported side effects of Deslorelin?

Reported side effects of Deslorelin include: Hot flashes, Bone density loss (prolonged suppression), Suppression of testosterone or estrogen, Mood changes, irritability, Decreased libido, Injection site reactions, Initial testosterone flare (clinical consideration).

Performance

Deslorelin

Q: What is the dosing range for Deslorelin?

Deslorelin is typically dosed at 50mcg (low), 100mcg (moderate), or 200mcg (high) mcg, administered Daily SC for continuous suppression; single or short course for pituitary reset. These ranges are aggregated from preclinical research and community protocols — not medical dosing guidance.

Also known as: SuvaPryn, Ovuplant, D-His6-Pro9-Et-GnRH

Share:Share on Reddit

Deslorelin is a veterinary and prescription compound. Research and informational use only.

📚 Content aggregated from:2 peer-reviewed sources·r/Peptides community·PubMed / NCBI

Overview

Potent GnRH super agonist approximately 100× more potent than native GnRH. Used in veterinary medicine for estrus suppression and in human medicine for precocious puberty treatment. In research protocols, used for pituitary desensitization to reset the HPG axis or induce controlled medical suppression of sex hormone production.

Research Summary

Deslorelin produces a robust initial LH/FSH surge (flare effect) followed by profound, sustained pituitary desensitization with continued exposure. This biphasic response is consistent across all high-affinity GnRH super agonists. The flare phase is exploited for reproductive timing in veterinary medicine; the desensitization phase creates the clinical suppression used in precocious puberty and research HPG axis reset protocols.

Dosing Range

low

50mcg

moderate

100mcg

high

200mcg

Units: mcg · Frequency: Daily SC for continuous suppression; single or short course for pituitary reset

Dosing ranges are aggregated from preclinical research and community protocols. Not medical dosing guidance.

Administration Routes

Subcutaneous implant (veterinary)Subcutaneous injection

Reconstitution Notes

Reconstitute with sterile water. Extremely potent — accurate dosing is critical. Measure with calibrated syringe. Store at -20°C. Stable 14–21 days refrigerated once reconstituted.

Step-by-step reconstitution guide →

Supplies you'll need

Insulin Syringes (U-100)Reconstitution Needles Lambda BAC Water Alcohol Prep Pads

Affiliate links — Research Stack may earn a small commission at no extra cost to you.

Reported Side Effects

Hot flashes
Bone density loss (prolonged suppression)
Suppression of testosterone or estrogen
Mood changes, irritability
Decreased libido
Injection site reactions
Initial testosterone flare (clinical consideration)

Research Papers

2 peer-reviewed sources

Deslorelin: pharmacology of a potent GnRH agonist

Journal of Clinical Endocrinology & Metabolism1989

Deslorelin implant for long-term GnRH-mediated suppression

Animal Reproduction Science2005

Community Experiences

Aggregated from public forums. Anecdotal — not clinical evidence.

r/Peptides

Community research discussion of deslorelin for HPG axis reset and comparison with triptorelin protocols.

View original thread

r/steroids

Discussion of GnRH agonist protocols using deslorelin for testosterone axis restart.

View original thread

Overview

Deslorelin acetate is a synthetic GnRH decapeptide super agonist, structurally distinguished from native GnRH by D-His substitution at position 6 and a Pro-Nhet modification at position 9. These changes dramatically increase GnRHR binding affinity and metabolic stability, making it approximately 100-fold more potent than natural GnRH.

Commercially, deslorelin is best known in veterinary medicine as SuvaPryn (for mare estrus induction) and Suprelorin (a subcutaneous implant for long-term testosterone suppression in male dogs, cats, and ferrets). The implant formulation provides continuous release over 6–12 months.

Mechanism

Receptor Pharmacology

Deslorelin occupies GnRH receptors on anterior pituitary gonadotrophs with extremely high affinity. The response depends entirely on the administration pattern:

Acute/single dose: Full agonist → massive LH and FSH surge → testosterone spike 4–6× above baseline within 4–8 hours

Continuous/repeated exposure: Receptor internalization → GnRHR downregulation → desensitization → castrate testosterone levels within 2–4 weeks

Comparison to Other GnRH Agonists

| Compound | Potency vs. GnRH | Primary use | |----------|-----------------|-------------| | Native GnRH | 1× | Reference | | Gonadorelin | ~1× | TRT adjunct | | Leuprolide | ~50× | Prostate cancer, endometriosis | | Triptorelin | ~100× | Prostate cancer, PCT | | Deslorelin | ~100× | Veterinary, precocious puberty | | Buserelin | ~100× | IVF stimulation |

Research Protocol Context

The most discussed research use of deslorelin involves short-course or single-dose administration to reset the HPG axis after prolonged androgen-induced suppression. The rationale parallels the triptorelin single-dose protocol:

The initial agonist flare stimulates robust LH release
Without follow-up dosing, the pituitary recovers normal GnRHR sensitivity
Recovery of endogenous testosterone production follows over subsequent weeks

Given deslorelin's extreme potency, exact dosing and avoiding repeat doses are critical safety parameters in any research protocol.

Veterinary Implant Context

The Suprelorin implant (4.7mg or 9.4mg deslorelin) is implanted subcutaneously and releases deslorelin for 6–12 months, maintaining castrate testosterone in male animals. This clinical data confirms long-term safety profile information in mammals, informing research in other contexts.